Angel Investment more important than ever
19th June 2017

The UK continues to enjoy a vibrant start up business culture

According to Companies House a record 650,000 new businesses were created in 20161. The data on the failure rate of start-up businesses varies but a recent report suggests that across Europe 60% of companies will not survive past 5 years2. A key factor that can determine the sustainability and eventual success of young and innovative companies is the availability of risk capital at an early stage. The early (or seed) stage of development is generally the most difficult time for companies to access external finance. Traditional banks, fund managers and even venture capital firms will typically not lend to or invest in early stage businesses as the risks are considered too great and the average transaction size too small to meet the criteria of these institutions. For many companies, investment provided by high net worth individuals (angels) and grant funding are the only sources of external finance open to them at this stage. Angel investors, who often have extensive business experience, constitute the most significant source of risk capital at the seed and early stage of company formation. In addition to cash, angel investors may also play a key role in providing strategic advice, credibility with funders and operational support for early stage businesses. In the UK the generous tax breaks for angel investors in the form of the Enterprise Investment Scheme (EIS) and the more recent Seed Enterprise Investment Scheme (SEIS) have underpinned the vitality of the provision of early stage risk capital. The EIS was launched in 1993 to “recognise that unquoted trading companies can often face considerable difficulties in realising relatively small amounts of share capital3.” Since that time 26,000 companies have raised £15.9 billion through EIS4. Oxford Innovation set up Oxford Investment Opportunity Investment Network (OION) in 1994 as one of the UK’s first angel networks to support this early stage investment activity. Since then our angel investors have invested in over 250 companies for a total amount of close to £40 million. In addition OION has established the OION SEIS/EIS fund in conjunction with investment managers Innvotec which invests alongside our angel investors. Venturefest, like OION, celebrates the critical role of the angel investor in supporting entrepreneurs and innovators thereby contributing to the success of Oxfordshire’s economy. OION are therefore delighted to support Venturefest Oxford, particularly in running the Pitching for success event.   1Centre for Entrepreneurs (CFE)’s analysis of the latest Companies House data. 2The UK 5-year survival rate for businesses born in 2010 and still active in 2015 was 41.4%. from ONS Statistical bulletin: Business demography, UK: 2015 3Michael Portillo, then Chief Secretary to the Treasury 4HMRC Key Statistics – April 2017: Enterprise Investment Scheme & Seed Enterprise Investment Scheme

About the author

Oxford Investment Opportunity Network
Jens is Managing Director of Oxford Investment Opportunity Network, Development Director SQW Group and Senior Advisor, Oxford Economics.

Latest news

Research, industry, and AGI

Research, industry, and AGI

A transfer of knowledge to industry is a good thing:  One purpose of a university is to benefit society by disseminating knowledge, and one way this can be done is by commercialising research. Universities and research institutions are a dynamo for entrepreneurship, and for innovation in large companies. READ MORE

For success in product development – start at square zero

For success in product development – start at square zero

When it comes to the commercial success of a technology-led product, there are a number of factors that come into play along the development journey. Have the regulatory requirements been met? Can the design be produced at a viable cost? Is it possible to ensure the quality of the manufacturing process? The list goes on. READ MORE

The not-so-small matter of scale: Making it big in microfluidics

The not-so-small matter of scale: Making it big in microfluidics

Microfluidics is a key technology enabling the development of rapid in-vitro diagnostics (IVD). With applications including COVID-19 testing, cardiac arrest assessment and STD screening, decentralised rapid diagnostics are shaping up to be a major part of the future of healthcare and wellness monitoring. READ MORE



Visit Britain

Keep in touch

Sign up to the Venturefest Oxford newsletter to make sure you are the first to hear the latest news. The next #vfestox newsletter will be coming out soon! Make sure you're on the list!






Email Preferences

Make connections that lead to new investments, new businesses and new ideas in the high-tech sector in Oxfordshire.